We unify genomics, transcriptomics, proteomics, and metabolomics into cohesive biological narratives. Our pipelines harmonize multi-layer molecular data to reveal disease mechanisms, drug targets, and biomarker signatures invisible to single-omics approaches.

We build agent-based and compartmental epidemic models (SIR, SEIR, SEIRD) to predict outbreak trajectories, evaluate intervention strategies, and assess population-level health risks. Models are calibrated with real-world surveillance and clinical data.

Our cloud-scalable pipelines process millions of biological data points — from NGS sequencing reads to mass spectrometry peaks — with automated quality control, feature extraction, and statistical analysis at population and single-cell resolution.

We deploy deep learning, graph neural networks, and transformer-based models for drug-target interaction prediction, protein structure analysis, clinical NLP, and biomarker discovery — bringing AI-driven precision to every stage of life-science research.

We deliver systems toxicology and computational risk assessment — integrating dose-response modeling, PBPK simulation, and adverse outcome pathway (AOP) analysis to evaluate chemical safety, drug toxicity, and environmental hazard for regulatory compliance.

We reconstruct genome-scale metabolic networks, protein interaction maps, and gene regulatory circuits to understand complex disease biology. Our network analysis identifies key hubs, essential pathways, and therapeutic vulnerabilities across cellular systems.

From molecular dynamics and Monte Carlo simulations to whole-organ virtual physiology, we model biological processes in silico. Our custom simulation frameworks support drug mechanism studies, disease progression modeling, and virtual clinical trials.

We transform raw EHR, clinical trial, and real-world health data into actionable intelligence using federated analytics, predictive modeling, and precision medicine frameworks — empowering clinicians and researchers with evidence-based, data-driven insights.